Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Why This Well-Timed Strategy is Forcing Them to Re-evaluate a Junior Oil Play in Texas

By Prodigy NewsG2 Energy Corp. is a Canadian, publicly-traded company (CSE:GTOO,OTCQB:GTGEF, FKN:UD9) focused on identifying and developing OVERLOOKED opportunities in the energy sector.The...
Research | July 14, 2022 |

Ovid Therapeutics Posts Positive Data from Phase 2 Seizure Reduction Trial

Ovid Therapeutics' shares are trading 25% higher today after the company reported positive initial data from its ENDYMION soticlestat phase 2 trial for patients with developmental and epileptic encephalopathies. Shares of Ovid Therapeutics Inc. (OVID:NASDAQ) are tra...
Streetwise Reports | September 25, 2019 |

Why Did ImmunoGen Plummet 32%?

This biotechnology company, which focuses on the treatment of cancer, received some feedback from the FDA that upset investors on Wednesday. ImmunoGen Inc.'s (IMGN:NASDAQ) shares closed down 32.06% on the NASDAQ Wednesday after announcing the United States ...
Streetwise Reports | May 21, 2019 |

PDS Biotech Collaborating with Merck in Phase 2 Cancer Trial

This morning PDS Biotechnology Corp. shares are trading 38% higher after reporting that it will enter into a clinical collaboration with Merck pairing the firm's PDS0101 with KEYTRUDA for patients with recurrent or metastatic head and neck cancer and high-risk HPV16 infection....
Streetwise Reports | October 4, 2019 |

Trillion Energy’s (CSE:TCF) Bayhanli-2 gas well enters production

Trillion Energy International Inc. ( CSE: TCF ) ( OTCQB: TRLEF ) (Frankfurt: Z62) announced flow test results for the Bayhanli-2 natural gas well at the SASB gas field, offshore Turkey. Eight intervals of gas pay with a true thickness of about 21 metres were perfor...
Maor Kagan | June 1, 2023 |

Top Cannabis Stocks

If you’re looking to invest in cannabis stocks, there are a couple of different approaches you can take. It helps to look at many types of companies in different parts of the industry and see which looks the most promising for your portfolio. The cannabis s...
Stockhouse Editorial | November 29, 2021 |

Immuno-Oncology Firm to Collaborate on Third Clinical Trial with Genentech

Descriptions of the new study and upcoming data readouts for this California-based firm were provided in an H.C. Wainwright & Co. report. In an April 29 research note, H.C. Wainwright & Co. analyst Swayampakula Ramakanth reported that Forty Seven Inc. (FTSV...
Streetwise Reports | May 2, 2019 |

Proteostasis Therapeutics Reports Positive Results from European Cystic Fibrosis Research

Proteostasis Therapeutics' shares traded higher today after the company reported positive results in its European Cystic Fibrosis study of organoids grown from human stem cells. The firm believes the ongoing ex-vivo study supports initiation of a human clinical trial in mid-20...
Streetwise Reports | December 12, 2019 |

SPY & QQQ Race For The New All-Time High Win.

Without too much attention from traders, the SPY and QQQ are racing to attempt to establish new all-time highs in what may become the most exciting Spring/Summer breakout rally of the past 3 years. While many other symbols are still flirting with November/December 2018 highs, ...
Chris Vermeulen | April 15, 2019 |

Bob Moriarty – Buying Opportunities of a Generation

https://www.streetwisereports.com/article/2019/11/19/bob-moriarty-mining-stocks-that-have-his-attention-right-now.html “In this exclusive interview, Bob Moriarty, founder of 321 Gold and 321 Energy, sits down with Maurice Jackson of Proven and Probable t...
Maurice Jackson | November 20, 2019 |
1 2 3 4 5 6 7 8 9 10 ...